Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Blaiss

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Pediatrics|October 20, 2023
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy optionMichael Blaiss, Lawrence DuBuske, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2011
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsMichael Blaiss, Jennifer Maloney, Hendrik Nolte, et al.
Allergy and Asthma Proceedings|December 6, 2021
Review of efficacy of ciclesonide for the treatment of asthma in childrenMichael Blaiss, William Berger, Bradley Chipps, et al.
Allergy and Asthma Proceedings|December 6, 2021
Safety of ciclesonide in children with asthma: A review of randomized controlled trialsMichael Blaiss, William Berger, Bradley Chipps, et al.
Current Medical Research and Opinion|September 22, 2023
Interdisciplinary collaboration in the diagnosis and management of chronic cough: the role and importance of primary care providersPeter V Dicpinigaitis, Kenneth W Altman, Isil Ulger Isci, et al.
Frontiers in Pediatrics|August 19, 2024
Degree of fear of needles and preferred allergy immunotherapy treatment among children with allergic rhinitis: caregiver survey resultsKaren Rance, Michael Blaiss, Payel Gupta, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 24, 2013
Author responseDésirée Larenas Linnemann, Enrico Compalati, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012Désirée Larenas-Linnemann, Michael Blaiss, Hugo P Van Bever, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 12, 2024
Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy AdultsMatthew Greenhawt, Jay Lieberman, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2010
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by classMichael Benninger, Judith R Farrar, Michael Blaiss, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Pediatrics|October 20, 2023
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy optionMichael Blaiss, Lawrence DuBuske, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2011
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsMichael Blaiss, Jennifer Maloney, Hendrik Nolte, et al.
Allergy and Asthma Proceedings|December 6, 2021
Review of efficacy of ciclesonide for the treatment of asthma in childrenMichael Blaiss, William Berger, Bradley Chipps, et al.
Allergy and Asthma Proceedings|December 6, 2021
Safety of ciclesonide in children with asthma: A review of randomized controlled trialsMichael Blaiss, William Berger, Bradley Chipps, et al.
Current Medical Research and Opinion|September 22, 2023
Interdisciplinary collaboration in the diagnosis and management of chronic cough: the role and importance of primary care providersPeter V Dicpinigaitis, Kenneth W Altman, Isil Ulger Isci, et al.
Frontiers in Pediatrics|August 19, 2024
Degree of fear of needles and preferred allergy immunotherapy treatment among children with allergic rhinitis: caregiver survey resultsKaren Rance, Michael Blaiss, Payel Gupta, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 24, 2013
Author responseDésirée Larenas Linnemann, Enrico Compalati, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012Désirée Larenas-Linnemann, Michael Blaiss, Hugo P Van Bever, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 12, 2024
Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy AdultsMatthew Greenhawt, Jay Lieberman, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 11, 2010
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by classMichael Benninger, Judith R Farrar, Michael Blaiss, et al.
Pageof 5